These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase. Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives. Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039 [TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to IA-2 in insulin-dependent diabetes mellitus. Measurements with a new immunoprecipitation assay. Masuda M; Powell M; Chen S; Beer C; Fichna P; Rees Smith B; Furmaniak J Clin Chim Acta; 2000 Jan; 291(1):53-66. PubMed ID: 10612717 [TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes. Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic islet cell cytoplasmic antibody in diabetes is represented by antibodies to islet cell antigen 512 and glutamic acid decarboxylase. Myers MA; Rabin DU; Rowley MJ Diabetes; 1995 Nov; 44(11):1290-5. PubMed ID: 7589826 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to glutamic acid decarboxylase in women who have had gestational diabetes. Beischer NA; Wein P; Sheedy MT; Mackay IR; Rowley MJ; Zimmet P Am J Obstet Gynecol; 1995 Nov; 173(5):1563-9. PubMed ID: 7503202 [TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of a radioimmunoprecipitation assay for IA-2 antibody and comparison of GAD antibody in type 1 diabetes mellitus. Ohta M; Ohta K; Obayashi H; Nakamura N; Shigeta H; Nakano K; Hasegawa G; Fukui M; Kitagawa Y; Nishimura M; Itoh N Autoimmunity; 2000 Sep; 32(2):79-88. PubMed ID: 11078153 [TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase. Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927 [TBL] [Abstract][Full Text] [Related]
15. Expression of recombinant human glutamic acid decarboxylase (GAD) in myeloma cells and enzyme-linked immunosorbent assay (ELISA) for autoantibodies to GAD. Matsuba T; Yano M; Abiru N; Takino H; Akazawa S; Nagataki S; Yasukawa K J Biochem; 1997 Jan; 121(1):20-4. PubMed ID: 9058186 [TBL] [Abstract][Full Text] [Related]
16. Association between antibodies to the MR 67,000 isoform of glutamate decarboxylase (GAD) and type 1 (insulin-dependent) diabetes mellitus with coexisting autoimmune polyendocrine syndrome type II. Seissler J; Bieg S; Yassin N; Mauch L; Northemann W; Boehm BO; Scherbaum WA Autoimmunity; 1994; 19(4):231-8. PubMed ID: 7578849 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Tuomi T; Groop LC; Zimmet PZ; Rowley MJ; Knowles W; Mackay IR Diabetes; 1993 Feb; 42(2):359-62. PubMed ID: 8425674 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
19. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. Vandewalle CL; Falorni A; Svanholm S; Lernmark A; Pipeleers DG; Gorus FK J Clin Endocrinol Metab; 1995 Mar; 80(3):846-51. PubMed ID: 7883841 [TBL] [Abstract][Full Text] [Related]
20. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. De Aizpurua HJ; Wilson YM; Harrison LC Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9841-5. PubMed ID: 1409709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]